CAR T-cell therapy

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  

CAR T-cell therapy
Jun 24, 2024, 22:06 | Blog
Nausheen Ahmed: Approvals, toxicity and access updates on CART
Nausheen Ahmed, Medical Director of BMT Survivorship Program at The University of Kansas, shared a…
Jun 20, 2024, 07:48 | Blog
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy
Vivek Subbiah shared a post on X: "Risk of Second Tumors and T-Cell Lymphoma after CAR…
Jun 18, 2024, 14:43 | Immune Oncology
CAR T Cell Therapy for Cancer Treatment
Introduction Chimeric antigen receptor - CAR T Cell therapy represents a groundbreaking approach in cancer…
Jun 14, 2024, 02:22 | Opinion
Harshal Chorya: Dr. Sam Yamshon captivating keynote on B-Cell Lymphomas
Harshal Chorya, HealthCare Professional at Baroda Medical College, shared a post on X: "Breakthrough Alert!…
Jun 13, 2024, 13:16 | Insight
Fabiana Perna: Our paper on novel toxicities of CAR T cell therapy
Fabiana Perna, Associate Member of Moffitt Cancer Center, shared on X: "Excited to share our paper…
May 31, 2024, 14:27 | Immune Oncology
How Does Immunotherapy Work
What is immunotherapy? Immunotherapy is a type of cancer treatment that uses the power of…
May 30, 2024, 16:14 | Blog
Alexander González: The challenges of CARNK existing in the process from lab production to tumor infiltration
Alexander González, Internal Clinician at 3cert Limited, shared on LinkedIn: “The challenges of CARNK existing…
May 28, 2024, 14:06 | Insight
Myeloma Paper of the Day, May 28th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Retrospective Memorial Sloan Kettering study suggests…
May 22, 2024, 13:51 | Blog
Gaurav Narula: Great two days brainstorming to help formulate the research questions for CAR T cell therapy
Gaurav Narula, Medical Oncologist at Postgraduate Institute of Medical Education and Research, Chandigarh, shared a…
May 21, 2024, 15:48 | Blog
Cancer Network - A panel of experts on multiple myeloma discuss the rationale for CAR T-cell therapy
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post by Cancer Network, on X: "So much fun…
May 21, 2024, 15:16 | Blog
A panel of experts on multiple myeloma discuss the rationale for CAR T-cell therapy - Cancer Network
Cancer Network shared a post on X: "A panel of experts on multiple myeloma discuss…
May 16, 2024, 15:09 | Insight
Myeloma Paper of the Day, May 16th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: DESCAR-T registry of French patients…
May 15, 2024, 10:54 | Dialogues
Oncothon: Challenges And Successes In Pediatric Hematology and Oncology
Oncothon is a telethon spanning 24 hours, dedicated to gathering donations for childhood cancer research.…
May 8, 2024, 13:50 | Opinion
NCI Center for Cancer Research - Alka Dwivedi was honored in this year's list of TIME100 Most Influential in Health
NCI Center for Cancer Research shared a post on LinkedIn: "IN THE NEWS: If you haven't…
May 3, 2024, 23:43 | Blog
Tanja Obradovic: All eyes are on ADCs coming from China's biotech innovation engine and CAR-T cell therapy
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON plc., shared a post on…
May 1, 2024, 10:09 | Blog
Amanda Impellizzeri: Thank you for making the West Virginia Oncology Society Spring Conference a success
Amanda Impellizzeri, Executive Director at Louisiana Oncology Society, posted on LinkedIn: "Thank you to all the…
Apr 28, 2024, 23:40 | Blog
Susanna Greer: Boosting the CAR T party
Susanna Greer, Chief Scientific Officer at the V Foundation for Cancer Research, published the following…
Apr 20, 2024, 18:05 | Insight
Nicolas Hubacz: T Cell Vs Cancer Cell
Nicolas Hubacz, Research Products Business Development Manager at Magstim, shared a post on LinkedIn: "CAR…
Apr 20, 2024, 17:31 | Blog
The U.S. FDA recently approved two CAR T-cell therapies for earlier treatment of adults with multiple myeloma - The Leukemia and Lymphoma Society
The Leukemia and Lymphoma Society shared a post on LinkedIn: "PROGRESS! The U.S. FDA recently approved…
Apr 16, 2024, 01:52 | Insight,Opinion
Angela Mastronuzzi: We investigated whether CAR T-cells directed towards the disialoganglioside GD2 can represent a potentially more effective treatment with reduced long-term side effects
Apr 15, 2024, 16:17 | Blog
Selwyn M. Vickers: MSK hosted a screening of the documentary Living Drugs
Selwyn M. Vickers, President and CEO at Memorial Sloan Kettering Cancer Center shared on X:…
Apr 11, 2024, 12:10 | Blog
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma, by Sumanta K. Pal et al - Cancer Discovery
Cancer Discovery shared on X/Twitter: "Just published with the AACR24 Clinical Plenary presentation: CD70-Targeted Allogeneic CAR…
Apr 9, 2024, 13:09 | Insight
New allogeneic CAR T cell therapy for advanced kidney cancer and an oncolytic immunotherapy for organ transplant patients with skin cancer - MD Anderson Cancer Center
MD Anderson Cancer Center shared on LinkedIn: ''At the 2024 American Association for Cancer Research Annual…
Apr 8, 2024, 21:58 | Blog,Insight
Katherine Masih: Super interesting work on activation of CAR-negative T-cells and subsequent cytotoxic killing of leukemia
Katherine Masih, Medical Student at University of Miami Miller School of Medicine, shared on X/Twitter:…
Apr 8, 2024, 16:03 | Insight
Gaurav Narula: India’s first CAR-T cell therapy
Gaurav Narula, Professor Paediatric Oncology and Health Sciences at Tata Memorial Center, shared the following…
Mar 28, 2024, 00:14 | Blog
E. Anders Kolb: LLS’s Chief Medical Officer Gwen Nichols recently addressed what patients need to know about CAR-T and what questions remain in her interview with CURE Media Group
Mar 20, 2024, 16:53 | Insight
Vincent Rajkumar: ODAC votes 11-0 to recommend approval of Cilta-Cel in patients with relapsed/refractory multiple myeloma in earlier stages
Vincent Rajkumar, Editor in Chief of Blood Cancer Journal, shared on X/Twitter: "Breaking: ODAC votes…
Mar 13, 2024, 22:40 | Insight
Gaurav Narula: When none believed, our institutions at Tata Memorial Hospital, IIT Bombay did
Gaurav Narula, Professor Pediatric Oncology and Health Sciences at Tata Memorial Center, shared an X…
Feb 25, 2024, 15:47 | Insight
Patrick Hwu: Did you know that CAR T-cell therapy could effectively treat autoimmune diseases?
Patrick Hwu, President and CEO at Moffitt Cancer Center, shared on X: "Did you know…
Feb 21, 2024, 18:18 | Insight
Vivek Subbiah: As of December 31, 2023, the FDA had become aware of 22 cases of T-cell cancers that occurred after treatment with CAR-T products
Vivek Subbiah shared on LinkedIn: "Perspective article on 'Secondary Cancers after Chimeric Antigen Receptor T-Cell…
Jan 19, 2024, 18:16 | Blog
Satya Prakash Yadav: Is chemotherapy free treatment of leukemia possible?
Satya Prakash Yadav, Director of Paediatric Hemato-Oncology and Bone Marrow Transplant at Medical and Haemato-Oncology…
Jan 10, 2024, 12:30 | Insight
Hung Trinh: Researchers Develop a Potential “Universal” CAR T-Cell Therapy for Blood Cancers
Hung Trinh, Director of Process Development and MFG Science and Technology at Vyriad, posted on LinkedIn:…
Dec 27, 2023, 17:10 | Blog
Julie Vose: She is a trooper and now sporting new hair and wearing lipstick!
Julie Vose shared a post by Nebraska Medicine on X/Twitter: "What a courageous strong woman!…
Dec 21, 2023, 16:55 | Blog
Sam Yamshon: Absolute tour de force by our fellow extraordinaire Mohammad Alhomoud
Sam Yamshon, Hematologist/Oncologist at Weill Cornell Medicine, shared on X/Twitter: "Absolute tour de force by…
Dec 21, 2023, 10:30 | Blog
MSKCC experts presented research related to managing and reducing treatment-related toxicities at the ASH - Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center shared on LinkedIn: ''Memorial Sloan Kettering Cancer Center (MSK) experts,…
Dec 19, 2023, 16:41 | Insight
Maria Natalia Gandur Quiroga: Pioneering Equity in Cancer Treatment: A Model Worth Emulating
Maria Natalia Gandur Quiroga shared on LinkedIn: "Pioneering Equity in Cancer Treatment: A Model Worth…
Dec 8, 2023, 12:47 | Insight
Talha Badar: A few selected ALL abstracts to watch for at ASH23
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter:…
Dec 1, 2023, 22:33 | Blog
Jose Vicente Cardona: Here are nine recent developments in the fight against cancer
Jose Vicente Cardona, Group Director Oncology, Global Medical Affairs at Roche, made the following post…
Nov 6, 2023, 17:36 | Blog
Manni Mohyuddin: Every day in my clinic, there is selection bias in favor of an increase in PFS for CAR T-cell therapy
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute at the University of Utah, shared…
Oct 20, 2023, 19:47 | Blog
Nicholas Vitanza: Thank you, Society of Research Administrators International
Nicholas Vitanza, Pediatric neuro-oncologist at Seattle Children's Hospital, shared on X/Twitter: "Thank you, Society of…
Oct 15, 2023, 18:02 | Insight
India's First Approved CAR-T Cell Therapy - No Longer Sci-Fi, Now a Reality! - ImmunoACT
ImmunoACT shared on Twitter: "A New Hope: India's First Approved CAR-T Cell Therapy - No…
Oct 12, 2023, 18:13 | Blog
María Natalia Gandur Quiroga: Fantastic review! A pleasure to read: Understanding the Cancer-Immunity Cycle.
Quoting María Natalia Gandur Quiroga on X/Twitter: "Fantastic review! A pleasure to read: Understanding the Cancer-Immunity…
Oct 10, 2023, 21:21 | Opinion
Manni Mohyuddin: Some days you see unjust racial disparities-such as Medicaid pts not covered for CAR-T.
Manni Mohyuddin, Assistant Professor in the Division of Hematology/Bone Marrow Transplant at the University of…
Sep 21, 2023, 18:12 | Insight
Fiona Hamilton Marshall: These are hopeful findings for patients with relapsed/refractory diffuse large B-cell lymphomawho may not have a durable response to existing therapies.
Sep 17, 2023, 18:02 | Blog
Patrick Hwu: We recently treated our 1,000th CAR T patient at the Moffitt Cancer Center with a comprehensive care team led by Drs. Brandon Blue and Ciara Freeman.
Patrick Hwu, the President and CEO at Moffitt Cancer Center, recently tweeted: ''We recently treated…
Sep 3, 2023, 05:14 | Insight
Dickran (Diko) Kazandjian: MRD in BM precedes CR in peripheral blood necessitating new definitions of MRD negativity independently of serum markers.
Dickran (Diko) Kazandjian, a Professor of Medicine at the Sylvester Comprehensive Cancer Center and a…
12
All: 146 Posts: 101 - 200
Special Coverage